Two new constituents from Erigeron breviscapus.

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Cell Biology

Background:

• Erigeron breviscapus (Compositae) is a plant source of bioactive compounds.
• Natural products often possess unique chemical structures with therapeutic potential.
• Understanding the chemical constituents of medicinal plants is crucial for drug discovery.

Purpose of the Study:

• To isolate and characterize novel chemical constituents from Erigeron breviscapus.
• To investigate the biological activity of the isolated compounds.

Main Methods:

• Phytochemical analysis involving isolation and purification techniques.
• Structure elucidation using spectral analyses (e.g., NMR, MS).
• In vitro assessment of cellular protective effects using human umbilical vein endothelial cells.

Main Results:

• Two novel compounds, erigeronones A (1) and B (2), were identified.
• Six known compounds were also isolated: apigenin-7-O-β-galacturonide (3), quercetin-7-O-β-glucuronide (4), quercetin-3-O-β-galacturonide (5), and eriodictyol-7-O-β-glucuronide (6).
• Erigeronone A exhibited significant protective effects against hydrogen peroxide-induced injury in human umbilical vein endothelial cells.

Conclusions:

• The study successfully identified new chemical entities from Erigeron breviscapus.
• The rare γ-pyrone moiety in erigeronones A and B is noteworthy.
• Erigeronone A shows promise as a protective agent for endothelial cells, warranting further investigation.